Tabrizi Peyman MD - Phoenix, Arizona 85013

Tabrizi Peyman MD is categorized under Doctors in Phoenix, AZ .

Business Name: Tabrizi Peyman MD
Contact Person: Peyman Tabrizi
Address: 2910 North 3rd Avenue, Phoenix, Arizona 85013
Phone Number: (602) 406-3181
Website Address: bnaneuro.net
Annual Revenue (USD): $500.000 to $999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:
Related Businesses: Greenspan David L MD - Phoenix, AZ 85013
Wahlheim Paul MD - Phoenix, AZ 85013
Mc Geever Kevin P MD - Phoenix, AZ 85013
Richard J Harding Md Pc - Phoenix, AZ 85013
Mcdougall Cameron G MD - Phoenix, AZ 85013
Smith Kris A MD - Phoenix, AZ 85013
Zabramski Joseph M MD - Phoenix, AZ 85013
Helligman Robert MD - Phoenix, AZ 85013
Sonntag Volker K MD - Phoenix, AZ 85013
Medchill Michael T MD - Phoenix, AZ 85013
Marc Darr Md - Phoenix, AZ 85013
Shamos Raymond F MD - Phoenix, AZ 85013
Muhammed Ali Parkinson Center - Phoenix, AZ 85013
Legris Gregory MD - Phoenix, AZ 85013
Daily William J R MD - Phoenix, AZ 85013
Schwartz Dawn M DO - Phoenix, AZ 85013
Wicklund Sarah E MD - Phoenix, AZ 85013
Shafer James W MD - Phoenix, AZ 85013
Fisher Kenneth M MD - Phoenix, AZ 85013
Holly Shill M D Pllc - Phoenix, AZ 85013

The company Tabrizi Peyman MD provides B2C services in the form of Doctors from its single location in Arizona. 1 to 4 employees work for Tabrizi Peyman MD, and the business now earns $500.000 to $999.999 per annum.

Tabrizi Peyman MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 . To contact Tabrizi Peyman MD, please call Peyman Tabrizi with the phone number (602) 406-3181 or visit its single location at 2910 North 3rd Avenue in Phoenix, Arizona 85013.

The location of the single location can also be found using the coordinates 33.48117,-112.07823. Read more details about this business on the webpage bnaneuro.net or follow the company’s social media accounts, on Twitter and on Facebook.